BJL
BNGO icon

Brighton Jones LLC’s Bionano Genomics BNGO Stock Holding History

Brighton Jones LLC’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-29
Closed -$45K – 484
2022
Q1 		$45K Hold
29
– – ﹤0.01% 507
2021
Q4 		$52K Hold
29
– – ﹤0.01% 520
2021
Q3 		$95K Buy
+29
New +$101K ﹤0.01% 471

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Brighton Jones LLC's BNGO Position: Q2 2022 in Review

Brighton Jones LLC sold out of Bionano Genomics (BNGO) in Q2 2022, closing a stake of 29 shares — an estimated $45K sold.

Brighton Jones LLC first reported a position in BNGO in Q3 2021 and held it in 3 quarters. The position peaked at $95K in Q3 2021. 143 funds tracked by Wall St. Rank hold BNGO as of Q2 2022.

  • Brighton Jones LLC reported no remaining Bionano Genomics position as of Q2 2022 after selling out during the quarter.
  • Brighton Jones LLC sold 29 Bionano Genomics shares in Q2 2022, an estimated $45K.
  • Brighton Jones LLC first reported a position in Bionano Genomics in Q3 2021 and held it in 3 quarters.
  • Brighton Jones LLC's Bionano Genomics position peaked at $95K in Q3 2021.
  • 143 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2022.

Based on Brighton Jones LLC's 13F filing for Q2 2022, filed 4 Aug 2022.